Ontruzant is a Intravenous Kit in the Human Prescription Drug category. It is labeled and distributed by Organon Llc. The primary component is .
| Product ID | 78206-148_ca182adf-2c29-47da-9e4e-e86e4b25cc49 |
| NDC | 78206-148 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ontruzant |
| Generic Name | Ontruzant |
| Dosage Form | Kit |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-06-01 |
| Marketing Category | BLA / |
| Application Number | BLA761100 |
| Labeler Name | Organon LLC |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-06-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-5033 | Ontruzant | trastuzumab |
| 0006-5034 | Ontruzant | Ontruzant |
| 78206-147 | Ontruzant | trastuzumab |
| 78206-148 | Ontruzant | Ontruzant |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ONTRUZANT 87405213 not registered Live/Pending |
Merck Sharp & Dohme Corp. 2017-04-10 |
![]() ONTRUZANT 86456110 not registered Dead/Abandoned |
Merck Sharp & Dohme Corp. 2014-11-17 |